- Home
- DIBS vs TLSA Comparison
DIBS vs TLSA Comparison
Compare DIBS & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DIBS
- TLSA
- Stock Information
- Founded
- DIBS 2000
- TLSA 2013
- Country
- DIBS United States
- TLSA United Kingdom
- Employees
- DIBS 284
- TLSA N/A
- Industry
- DIBS Catalog/Specialty Distribution
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- DIBS Consumer Discretionary
- TLSA Health Care
- Exchange
- DIBS Nasdaq
- TLSA Nasdaq
- Market Cap
- DIBS 86.4M
- TLSA 87.8M
- IPO Year
- DIBS 2021
- TLSA 2000
- Fundamental
- Price
- DIBS $2.45
- TLSA $1.07
- Analyst Decision
- DIBS Hold
- TLSA
- Analyst Count
- DIBS 1
- TLSA 0
- Target Price
- DIBS N/A
- TLSA N/A
- AVG Volume (30 Days)
- DIBS 123.8K
- TLSA 363.4K
- Earning Date
- DIBS 05-09-2025
- TLSA 05-09-2025
- Dividend Yield
- DIBS N/A
- TLSA N/A
- EPS Growth
- DIBS N/A
- TLSA N/A
- EPS
- DIBS N/A
- TLSA N/A
- Revenue
- DIBS $88,257,000.00
- TLSA N/A
- Revenue This Year
- DIBS $5.47
- TLSA N/A
- Revenue Next Year
- DIBS $6.46
- TLSA N/A
- P/E Ratio
- DIBS N/A
- TLSA N/A
- Revenue Growth
- DIBS 4.22
- TLSA N/A
- 52 Week Low
- DIBS $2.30
- TLSA $0.49
- 52 Week High
- DIBS $6.20
- TLSA $1.91
- Technical
- Relative Strength Index (RSI)
- DIBS 31.53
- TLSA 53.21
- Support Level
- DIBS $2.33
- TLSA $0.76
- Resistance Level
- DIBS $2.49
- TLSA $1.13
- Average True Range (ATR)
- DIBS 0.20
- TLSA 0.11
- MACD
- DIBS -0.00
- TLSA -0.00
- Stochastic Oscillator
- DIBS 17.34
- TLSA 85.00
About DIBS 1stdibs.com Inc.
1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The Company has a single reportable and operating segment that contains one reporting unit, which consists of the Company's online marketplace that enables commerce between sellers and buyers. The company generates maximum revenue from fees from seller marketplace services and other services, including advertisements.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.